替米沙坦片治疗原发性高血压的疗效研究

Clinical Effect of Telmisartan Tablets on Essential Hypertension

目的分析替米沙坦片治疗原发性高血压的临床疗效。方法选取我院2013年收治的40例原发性高血压患者为研究对象,并将其随机分为对照组和试验组,每组20例。对照组采用非洛地平治疗,试验组采用替米沙坦片治疗。观察两组患者治疗前后血压变化及治疗期间不良反应情况。结果两组患者治疗前收缩压、舒张压比较,差异无统计学意义(P>0.05);试验组患者治疗后收缩压与舒张压均低于对照组,差异有统计学意义(P<0.05)。试验组患者总有效率为90%(18/20),高于对照组的60%(12/20),差异有统计学意义(P<0.05)。两组患者治疗期间均未出现严重不良反应。结论替米沙坦治疗原发性高血压疗效显著,且不良反应较小。

Objective To analyze the clinical effect of the telmisartan tablets on essential hypertension. Methods A total of 40 patients with essential hypertension admitted in our hospital in 2013 were selected and randomly divided into control group and experiment group,20 cases in each group. Control group given felodipine,while experiment group given telmisartan tablets. Blood pressure before and after treatment,incidence of adverse reactions during treatment were observed. Results There was no statistical significances of SBP and SDP between two groups before treatment（ P〉0. 05）;while SBP and SDP of experiment group were lower than those of control group,the differences were statistically significant（P〈0. 05）. The total ef-fective rate of experiment group was 90%（18/20）,was higher than that of the control group of 60%（12/20）,the difference was statistically significant（P〈0. 05）. No one of the two groups occurred serious adverse reactions during treatment. Conclu-sion Telmisartan tablets is effective in the treatment of essential hypertension,with less adverse reactions.